NA Implantable Ports Market - Industry Trends and Forecast to 2030

TABLE OF CONTENT

1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 OVERVIEW OF THE NORTH AMERICA IMPLANTABLE PORTS MARKET 12
1.4 CURRENCY AND PRICING 13
1.5 LIMITATIONS 13
1.6 MARKETS COVERED 13
2 MARKET SEGMENTATION 15
2.1 MARKETS COVERED 15
2.2 GEOGRAPHICAL SCOPE 16
2.3 YEARS CONSIDERED FOR THE STUDY 17
2.4 Cognate Lifesciences TRIPOD DATA VALIDATION MODEL 18
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 21
2.6 MULTIVARIATE MODELLING 22
2.7 TYPE SEGMENT LIFELINE CURVE 22
2.8 MARKET END USERS COVERAGE GRID 23
2.9 Cognate Lifesciences MARKET POSITION GRID 24
2.10 VENDOR SHARE ANALYSIS 25
2.11 SECONDARY SOURCES 26
2.12 ASSUMPTIONS 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 29
4.1 CONSUMER BUYING BEHAVIOUR 30
4.2 FACTORS AFFECTING BUYING DECISION 30
4.3 PRODUCT ADOPTION SCENARIO 30
4.4 REGULATION COVERAGE 31
4.5 BRAND ANALYSIS 33
4.6 RAW MATERIAL SOURCING ANALYSIS 34
4.7 IMPORT EXPORT SCENARIO 34
4.8 PORTER'S 5 FORCES 36
5 SUPPLY CHAIN ANALYSIS 37
5.1 LOGISTIC COSTS SCENARIO 37
5.2 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS 37
6 MARKET OVERVIEW 39
6.1 DRIVERS 41
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 41
6.1.2 GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 41
6.1.3 INCREASING ONCOLOGY AND CHEMOTHERAPY PROCEDURES 42
6.1.4 IMPROVED DEVICE DESIGN AND FUNCTIONALITY 42
6.2 RESTRAINTS 43
6.2.1 RISK OF INFECTIONS AND MECHANICAL COMPLICATIONS 43
6.2.2 STRINGENT REGULATORY REQUIREMENTS FOR APPROVAL PROCESS 43
6.3 OPPORTUNITIES 44
6.3.1 RISING DEMAND FOR IMPLANTABLE PORT DEVICES DUE TO HIGH SUCCESS RATE 44
6.3.2 EXPANSION OF HOME-BASED HEALTHCARE 44
6.4 CHALLENGES 45
6.4.1 LACK OF SKILLED PROFESSIONALS OR EXPERTISE 45
6.4.2 PRODUCT RECALL OF IMPLANTABLE PORT DEVICES 45
7 NORTH AMERICA IMPLANTABLE PORTS MARKET, BY TYPE 47
7.1 OVERVIEW 48
7.2 SINGLE LUMEN 51
7.3 DOUBLE LUMEN 51
7.4 POWER- INJECTABLE 52
8 NORTH AMERICA IMPLANTABLE PORTS MARKET, BY MATERIAL 53
8.1 OVERVIEW 54
8.2 POLYURETHANE 57
8.3 SILICONE 57
8.4 TITANIUM 58
8.5 OTHERS 59
9 NORTH AMERICA IMPLANTABLE PORTS MARKET, BY APPLICATION 60
9.1 OVERVIEW 61
9.2 CHEMOTHERAPY 64
9.3 BLOOD TRANSFUSION 64
9.4 ANTIBIOTICS 65
9.5 INTRAVENOUS INFUSION OF BLOOD PRODUCT 66
9.6 PAIN MANAGEMENT 66
9.7 OTHERS 67
10 NORTH AMERICA IMPLANTABLE PORTS MARKET, BY END USERS 68
10.1 OVERVIEW 69
10.2 HOSPITALS 72
10.3 CLINICS 72
10.4 AMBULATORY SURGICAL CENTER 73
10.5 DIALYSIS CENTER 73
10.6 OTHERS 75
11 NORTH AMERICA IMPLANTABLE PORTS MARKET, BY REGION 76
11.1 NORTH AMERICA 77
11.1.1 U.S. 83
11.1.2 CANADA 85
11.1.3 MEXICO 87
12 NORTH AMERICA IMPLANTABLE PORTS MARKET: COMPANY LANDSCAPE 89
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 89
13 SWOT 90
14 NORTH AMERICA IMPLANTABLE PORTS MARKET, COMPANY PROFILE 91
14.1 B.BRAUN SE 91
14.1.1 COMPANY SNAPSHOT 91
14.1.2 COMPANY SHARE ANALYSIS 91
14.1.3 PRODUCT PORTFOLIO 92
14.1.4 RECENT DEVELOPMENTS 92
14.2 ANGIODYNAMICS 93
14.2.1 COMPANY SNAPSHOT 93
14.2.2 REVENUE ANALYSIS 93
14.2.3 COMPANY SHARE ANALYSIS 94
14.2.4 PRODUCT PORTFOLIO 94
14.2.5 RECENT DEVELOPMENT 94
14.3 BD 95
14.3.1 COMPANY SNAPSHOT 95
14.3.2 REVENUE ANALYSIS 95
14.3.3 COMPANY SHARE ANALYSIS 96
14.3.4 PRODUCT PORTFOLIO 96
14.3.5 RECENT DEVELOPMENT 96
14.4 TELEFLEX INCORPORATED 97
14.4.1 COMPANY SNAPSHOT 97
14.4.2 REVENUE ANALYSIS 97
14.4.3 COMPANY SHARE ANALYSIS 98
14.4.4 PRODUCT PORTFOLIO 98
14.4.5 RECENT DEVELOPMENTS 98
14.5 VYGON 99
14.5.1 COMPANY SNAPSHOT 99
14.5.2 COMPANY SHARE ANALYSIS 99
14.5.3 PRODUCT PORTFOLIO 100
14.5.4 RECENT DEVELOPMENT 100
14.6 AMI GMBH 101
14.6.1 COMPANY SNAPSHOT 101
14.6.2 PRODUCT PORTFOLIO 101
14.6.3 RECENT DEVELOPMENT 101
14.7 DISTRICLASS MÉDICAL 102
14.7.1 COMPANY SNAPSHOT 102
14.7.2 PRODUCT PORTFOLIO 102
14.7.3 RECENT DEVELOPMENT 102
14.8 ICU MEDICAL, INC. 103
14.8.1 COMPANY SNAPSHOT 103
14.8.2 REVENUE ANALYSIS 103
14.8.3 PRODUCT PORTFOLIO 104
14.8.4 RECENT DEVELOPMENT 104
14.9 PAKUMEDMEDICAL PRODUCTS GMBH 105
14.9.1 COMPANY SNAPSHOT 105
14.9.2 PRODUCT PORTFOLIO 105
14.9.3 RECENT DEVELOPMENTS 105
15 QUESTIONNAIRE 106
16 RELATED REPORTS 109